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ABSTRACT 
Autism is most common neurodevelopmental disorder seen in pediatric population. The ratio of autism 
spectrum disorder nowadays increasing day by day according to Indian statistical data. In autism child 
generally have poor socialization, communication and speech issue which is normal in few months of the 
age and start regress in second years of life. In field of rehabilitation autism has better results by 
occupational therapy, speech therapy and early intervention. In this study we tried the Centella asiatica 
extract in form of Brahmi to treat many clinical symptoms such as cognition, poor attention span, 
hyperactivity, not responding name in autistic children. The outcome measure Childhood Autism Rating 
Scale and Vineland Social Maturity Scale were used for pre and post test assessment and after the statistical 
analysis the result suggested that experimental group have more significance result that is p< 0.01 in 
experimental group than control group that is p<0.09. It also suggested that score of CARS and VSMS show 
maximum change by employing Brahmi with other rehabilitation intervention in autistic kids.  
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INTRODUCTION 
 Autism in this era is the most common 
developmental disorder seen in pediatric population. It is 
associated with impaired both verbal and nonverbal 
communication, reciprocal social interactions poor 
interaction with peer groups, poor socialization, self-
occupancy and poor social skills. In autism most children 
reach their development milestone according to their 
normal age and then regress[1]. Autism is caused by a 
combination of genetic and environmental factors[2]. 
According to diagnostic and statistical manual of mental 
health IV (DSM) autism comes under the autism spectrum 
disorders where there is lacks in cognitive and language 
development. According to statistical data of center for 
disease control and prevention (CDC), every one child has 
autism out of 68 children[3]. Brahmi is one of a group of 
plant extracts obtained from the plant: Centella asiatica 
(Linn.) Urban, which has been used extensively as memory 
enhancer and brain repairer by Ayurveda Physicians. It 
has a quality to regeneration and enhancement of brain 
repair. The name, Brahmi, is named after one of the highest 
states of consciousness (Brahman or God of 
consciousness), Brahmi (Centella asiatica or Gotu Kola) is 
one of the most powerful brain tonics in the Ayurvedic 
medicine. It supports restful sleep, calms emotional 
turbulence, and simultaneously improves concentration 
and alertness. In cognitive enhancement area specially in 
case of autism, these children have very good visual 
cognition seen in autism according to research by 
university Norkinptom, UK. This study is conducted on 
autism spectrum children for see the changes in their 
cognitive and quality of life by employing Brahmi 
medication.  
Materials and methods 
Subjects 
 Diagnosed cases of Autism spectrum disorders 
referred by clinical psychologist according to childhood 
rating scale (CARs), autism treatment evaluation checklist 
(ATEC) and Vinland social maturity scales (VSMS) were 
used by the clinical psychologist to diagnosed the case for 
Brahami treatment and on those subjects who comes 
under the norms of selection criteria. The inclusion criteria 
were Children diagnosed as Autism using the DSM IV or V 
Autism Criteria, certified to be in adequate healthy state by 
panel Pediatrician or Physician, age group 2 to 10 years 
and of either sex, well-educated parents who can 
understand the experimental nature of the study, and can 
give informed voluntary written permission for inclusion 
of their autistic child for this study. The exclusion criteria 
were as followed children having any genetic disabilities 
or cerebral palsy, insufficiency of liver / kidney / marrow 
functions as per appropriate biochemical tests, chronic 
uncontrolled illness that may need medical therapy which 
could interfere with diagnosis, treatment and assessment 
of the Autism symptoms. 
Methods  
 Before recruiting the subjects inform consent 
form the parent of selected children were collected. The 
duration and process of Brahmi treatment explained to the 
parent whose children enrolled in the ongoing study. The 
duration of Bhrami medication was three month after 
enrollment of the subject in the study. All biochemical 
testing were performing to justify the normal health 
condition before starting the Brahmi treatment. 
Int. J. Ayur. Pharma Research, 2017;5(5):62-64 
 Available online at: http://ijapr.in   63 
 The composition of Brahmi medicines includes Centella 
asiatica, Piper nigrum, Prunus amygdalus, Emblica 
officinalis, phoenix dactylifera and delphinium denudatum 
wall which is already provided by CCRU to the UDAAN for 
the treatment purpose. Dose of the Brahmi medicine 
depends on the weight of per child which is shown as in 
table -1. 
Table 1: Dosage of Brahmi according to weight of the child 
S. No Weight         Dose for Brahmi 
1 10-20Kg 2.5ml morning   2.5 ml evening 
2 20-30Kg 2.5ml morning 5ml evening 
3 30-40Kg 5ml morning 5ml evening 
4 40-50Kg 5ml morning 7.5 ml evening 
5 50-60Kg 7.5ml morning 7.5ml evening 
6 Above 60Kg 10ml morning 10ml evening 
 In this study the subjects recruited between the 
age group 2 to 10 years proved to have autism according 
to criteria DSM-IV and CARS scoring. Total twenty subject 
who comes under the inclusion and exclusion criteria were 
divided into two groups named as Experimental group 
(EG) and control group (CG) for the Brahmi medication 
treatment. Before stating the Brahmi treatment pre 
assessment called pretest data and after the completion of 
3 month Brahmi treatment called post assessment data 
were conducted to collect the data for statistical analysis 
using the following outcome measures such as Vineland 
Social Maturity Scale (VSMS) and Childhood Autism Rating 
Scale (CARS).  
Outcome Measures  
 Childhood autism rating scale (CARs) and 
Vineland Social Maturity Scale (VSMS) were used as 
outcome measure for statistical analysis.  CARs and VSMS 
both are the internationally approved scale for the 
assessment of level of autism and developmental 
component in neurodevelopmental disability. 
 In childhood autism rating scale (CARS) [4] is a 15 
item behavioral rating scale developed to identify children 
with autism, and to distinguish them from 
developmentally handicapped children without the autism 
syndrome. CARS is especially effective in discriminating 
between autistic children and trainable mentally retarded 
children. It was designed to help differentiate children 
with autism from those with other developmental delays, 
such as intellectual disability. 
 Vineland Social Maturity Scale (VSMS) [5] is a 
uniquely useful instrument for assessing social maturity of 
children and young adults. It is used for measure many 
domains such as mental status social maturity and 
developmental milestone in may neurodevelopmental 
disorders such as cerebral palsy, down syndrome and 
autism.  
RESULT  
 After the statistical data analysis using SPSS 20.0 
(Armonk, NY, IBM Corp.USA) and Microsoft Excel 2010. 
The results show significant improvement in both the 
groups (CG and EG) as shown in table-2. The result also 
show more significant results in EG that is p<0.01as 
compare to CG that is p<0.09, where p-value of less that 
0.05 is considered statistically significant. 









Pre Post Mean Change P-Value 
Control Group 36.28 50.02  31.50+3.26 34.78+12.72 3.28 0.09 
Experimental Group 33.56 46.5   31.50+2.52 19.79+17.91 11.71 0.01* 
*p-value<0.05 is taken as significant 
 In EG mean change score are 11.71 as compare to 
CG that is 3.28 which also show significant changes in EG 
and shows that Brahmi medication with occupational 
therapy helps in improvement of social skill as well as 
cognitive changes in autistic children. It also suggested 
that the rate of progress of improvement can be improved 
by using Brahmi medication along with occupational 
therapy rather than only occupational therapy alone. 
DISCUSSION AND CONCLUSION 
 Now a day study of natural and herbal products 
used in traditionally medicine increasing day by day. 
Brahmi is one of the herbal medicines which are more 
popular for cognitive enhancement [6] and coronary heart 
disease management[7]. If we talk about autism, these 
children have very good visual cognition but there is need 
to stimulate it in prospective and purposive manner. 
Brahmi medication has good results in cognitive 
enhancement in many diseases such as human memory [8-
9]. We concluded that from our result Brahmi medication 
along with conservative treatment approached such as 
occupational therapy, play therapy and early intervention 
may enhances the rate of progress in quality of life (QOL) 
of autistic kids. In future this medicine can play important 
role to make these kinds in inclusion training schools also. 
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